343 related articles for article (PubMed ID: 22763383)
1. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of renal function in patients with cardiac resynchronization therapy.
Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
[TBL] [Abstract][Full Text] [Related]
3. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
[TBL] [Abstract][Full Text] [Related]
5. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
[TBL] [Abstract][Full Text] [Related]
6. Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis.
Mantziari L; Guha K; Khalique Z; McDonagh T; Sharma R
Am J Cardiol; 2012 Jun; 109(11):1619-25. PubMed ID: 22465318
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.
van Bommel RJ; Borleffs CJ; Ypenburg C; Marsan NA; Delgado V; Bertini M; van der Wall EE; Schalij MJ; Bax JJ
Eur Heart J; 2010 Nov; 31(22):2783-90. PubMed ID: 20693544
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
[TBL] [Abstract][Full Text] [Related]
9. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
[TBL] [Abstract][Full Text] [Related]
11. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
[TBL] [Abstract][Full Text] [Related]
12. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
13. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.
Moreira RI; Cunha PS; Rio P; da Silva MN; Branco LM; Galrinho A; Feliciano J; Soares R; Ferreira RC; Oliveira MM
J Interv Card Electrophysiol; 2018 Apr; 51(3):237-244. PubMed ID: 29460235
[TBL] [Abstract][Full Text] [Related]
14. Right ventricular function and survival following cardiac resynchronisation therapy.
Leong DP; Höke U; Delgado V; Auger D; Witkowski T; Thijssen J; van Erven L; Bax JJ; Schalij MJ; Marsan NA
Heart; 2013 May; 99(10):722-8. PubMed ID: 23315608
[TBL] [Abstract][Full Text] [Related]
15. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
17. Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response.
Verbrugge FH; Dupont M; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Heart; 2013 Mar; 99(5):314-9. PubMed ID: 23038789
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
[TBL] [Abstract][Full Text] [Related]
20. Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.
Van Bommel RJ; Mollema SA; Borleffs CJ; Bertini M; Ypenburg C; Marsan NA; Delgado V; Van Der Wall EE; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2011 Feb; 57(5):549-55. PubMed ID: 21272745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
